![]() |
|
|
Vol. 301, Issue 1, 197-209, April 2002
Psychiatric Institute, Department of Psychiatry, University of
Illinois at Chicago, Chicago, Illinois
The present study was undertaken to examine whether the mechanism of
action of typical and atypical antipsychotics is related in their
ability to regulate key phosphorylating enzyme of adenylyl cyclase-cAMP
pathway, i.e., protein kinase A (PKA). For this purpose, regulatory (R)
and catalytic (Cat) activities of PKA and expression of various
isoforms of regulatory and catalytic subunits were examined in rat
brain after single or chronic (21-day) treatment with haloperidol (HAL,
1 mg/kg) or clozapine (CLOZ, 20 mg/kg). It was observed that chronic
but not acute treatment of CLOZ significantly decreased
[3H]cAMP binding to the regulatory subunit of PKA as well
as catalytic activity of PKA in particulate and cytosol fractions of
the rat cortex, hippocampus, and striatum. In these fractions, CLOZ
significantly decreased protein levels of selective RII
-, RII
-,
and Cat
-subunit isoforms of PKA. These decreases were accompanied by
decreases in their respective mRNA expression. In contrast, chronic but not acute treatment of HAL significantly increased
[3H]cAMP binding and the catalytic activity of PKA in
particulate and cytosol fractions of only the striatum brain area. In
addition, chronic treatment of HAL significantly increased mRNA and
protein levels of RII
- and RII
-subunit isoforms in the striatum.
None of the antipsychotics caused any change in the expression of the Cat
-, RI
-, or RI
-subunit isoform. These results, thus, suggest that HAL and CLOZ differentially regulate PKA catalytic and regulatory activities and the expression of selective catalytic and regulatory subunit isoforms of PKA, which may be associated with their mechanisms of action.
This article has been cited by other articles:
![]() |
J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al. Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection Pharmacol. Rev., September 1, 2008; 60(3): 358 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. de Pina, H. Vazquez-Meza, J. P. Pardo, J. L. Rendon, R. Villalobos-Molina, H. Riveros-Rosas, and E. Pina Signaling the Signal, Cyclic AMP-dependent Protein Kinase Inhibition by Insulin-formed H2O2 and Reactivation by Thioredoxin J. Biol. Chem., May 2, 2008; 283(18): 12373 - 12386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Ahmed, V. V. Gurevich, K. N. Dalby, J. L. Benovic, and E. V. Gurevich Haloperidol and Clozapine Differentially Affect the Expression of Arrestins, Receptor Kinases, and Extracellular Signal-Regulated Kinase Activation J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Culm and R. P. Hammer Jr. Recovery of Sensorimotor Gating without G Protein Adaptation after Repeated D2-Like Dopamine Receptor Agonist Treatment in Rats J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 487 - 494. [Abstract] [Full Text] [PDF] |
||||